<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20424" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Dexmedetomidine</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reel</surname>
            <given-names>Bradley</given-names>
          </name>
          <aff>Uniformed Services University of Health</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maani</surname>
            <given-names>Christopher V.</given-names>
          </name>
          <aff>US Army; USUHS; BAMC; UTHSCSA; UIW</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bradley Reel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Maani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20424.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">The FDA-approved indications for dexmedetomidine are sedation of intubated and mechanically ventilated patients in the intensive care unit (ICU) and peri-procedural (or peri-operative) sedation of non-intubated patients. Over time, usage has expanded to off-label uses, including treatment and prevention of delirium, adjunctive analgesia, therapy for insomnia in the ICU, and treatment of alcohol withdrawal. Dexmedetomidine has also been used in peripheral nerve blocks to prolong the duration of analgesia. This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of dexmedetomidine, pertinent for members of the interprofessional team in treating patients where anesthesia is appropriate.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the mechanism of action of dexmedetomidine.</p></list-item><list-item><p>Summarize the indicated uses for dexmedetomidine.</p></list-item><list-item><p>Review the adverse effect profile and contraindications of dexmedetomidine.</p></list-item><list-item><p>Explain the importance of improving care coordination among the interprofessional team to enhance care delivery for patients when using dexmedetomidine as an anesthesia agent.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20424&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20424">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20424.s2" sec-type="Indications">
        <title>Indications</title>
        <p>The FDA-approved indications for dexmedetomidine are sedation of intubated and mechanically ventilated patients in the intensive care unit (ICU) and peri-procedural (or peri-operative) sedation of non-intubated patients. Over time, usage has expanded to off-label uses, including treatment and prevention of delirium, adjunctive analgesia, therapy for insomnia in the ICU, and treatment of alcohol withdrawal. This expanded list of indications is because it commonly produces a sedated state allowing patients to be comfortable and cooperative during mechanical ventilation. Additionally, it does not require stoppage to accomplish extubation and is safe to use in non-intubated patients because it does not produce significant respiratory depression. Given THAT inherent analgesic properties are rare with&#x000a0;most sedatives, dexmedetomidine produces an opioid-sparing effect.<xref ref-type="bibr" rid="article-20424.r1">[1]</xref></p>
        <p>ICU sedation with dexmedetomidine has been demonstrated to decrease the incidence and duration of delirium and delay the onset of delirium compared with other sedatives.<xref ref-type="bibr" rid="article-20424.r2">[2]</xref> Evidence also exists that there is a reduction in both the time to extubation and the number of ventilator-dependent hours in patients with delirium.<xref ref-type="bibr" rid="article-20424.r3">[3]</xref> These reductions may be related to the ability of dexmedetomidine to reduce the need for other medications&#x000a0;(for example, propofol, benzodiazepines, opioids)&#x000a0;to promote a comfortable/cooperative patient. This effect has been particularly useful in the treatment of elderly post-cardiac surgery patients.<xref ref-type="bibr" rid="article-20424.r4">[4]</xref>&#x000a0;The beneficial effects&#x000a0;in this particular patient population extend into longer outcomes, including survival at two years and improved cognitive function and quality of life. It has also&#x000a0;become common to treat poor sleep in the ICU with dexmedetomidine infusions at doses as high as 1.5 mcg/kg per hr. This practice&#x000a0;is supported by research showing dexmedetomidine often yields sleep quality closely related to stage 2 non-REM sleep.<xref ref-type="bibr" rid="article-20424.r5">[5]</xref> However, it is also important to note that there is data showing alteration of normal sleep patterns, and subjects achieve no restorative rapid-eye-movement or slow-wave sleep. Additionally, studies demonstrating the benefit in clinical outcomes related to improved sleep generated by dexmedetomidine are sparse.<xref ref-type="bibr" rid="article-20424.r6">[6]</xref></p>
        <p>Dexmedetomidine is commonly used in anesthesia practice as well. It is used for procedural sedation for a variety of operations. It is also used frequently for sedation during the performance of awake intubation. It is ideally suited for this indication for the reasons stated above. Dexmedetomidine is also an adjunct infusion during general anesthesia. There is evidence that dexmedetomidine decreases postoperative pain, postoperative opioid usage, and nausea.<xref ref-type="bibr" rid="article-20424.r7">[7]</xref> This effect has also been shown to be present when using dexmedetomidine for sedation during procedures performed under spinal anesthesia.<xref ref-type="bibr" rid="article-20424.r8">[8]</xref> However, at least one recent study has been called into question this opioid-sparing effect for a cohort of patients undergoing major spine surgery.<xref ref-type="bibr" rid="article-20424.r9">[9]</xref> There has been some interest in using dexmedetomidine as an adjunct to prevent emergence agitation, postoperative delirium, and postoperative cognitive dysfunction. There is evidence for the prevention of emergence agitation in both children and adults.<xref ref-type="bibr" rid="article-20424.r10">[10]</xref>
<xref ref-type="bibr" rid="article-20424.r11">[11]</xref>Because of enthusiasm over apparent prevention/treatment of delirium with dexmedetomidine when used for ICU sedation, it was hoped this benefit would be reproduced for postoperative delirium when using an intraoperative infusion of dexmedetomidine; however, a recent randomized trial did not show a statistically significant benefit in this postoperative population.<xref ref-type="bibr" rid="article-20424.r12">[12]</xref> Dexmedetomidine has also been used in peripheral nerve blocks to prolong the duration of analgesia. Research suggests the dexmedetomidine may extend the duration of a peripheral nerve block for approximately 3 hours.<xref ref-type="bibr" rid="article-20424.r13">[13]</xref></p>
      </sec>
      <sec id="article-20424.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Dexmedetomidine is an alpha agonist having sedative, anxiolytic, hypnotic, analgesic, and sympatholytic properties. It produces these effects by inhibiting central sympathetic outflow by blocking the alpha receptors in the brainstem, thereby inhibiting the release of norepinephrine. It has a selectivity of 1600 to 1 for the alpha2 receptor as compared to alpha1. This selectivity is especially significant compared to another alpha agonist, clonidine, with a selectivity of 220 to 1.&#x000a0;The mechanism by which dexmedetomidine may increase the duration of a peripheral nerve block is not fully understood but is believed to most likely be a perineural mechanism rather than a systemic or central mechanism, which appears to prolong the duration by blocking the cation current.<xref ref-type="bibr" rid="article-20424.r14">[14]</xref></p>
      </sec>
      <sec id="article-20424.s4" sec-type="Administration">
        <title>Administration</title>
        <p>For ICU sedation, the typical dosage range is 0.2 to 0.7 mcg/kg per hour. However, the dose can increase to 1.5 mcg/kg&#x000a0;per hour&#x000a0;to achieve the desired sedation level. Doses as high as 2.5 mcg/kg&#x000a0;per hour&#x000a0;have been described, but it is unlikely that doses higher than 1.5 mcg/kg&#x000a0;per hour achieve any further therapeutic benefit in the absence of increased side effects. Dosage adjustments for renal or hepatic impairment are not required but should be considered, especially for hepatic impairment. The manufacturer does not recommend durations longer than 24 hours; however, longer durations have been demonstrated&#x000a0;as safe and effective. Clinicians can administer a loading dose of 0.5 to 1.0 mcg/kg; this is usually avoidable if the medication is for labile critically ill patients or those with tenuous hemodynamics.</p>
        <p>When used in anesthesia, the typical dosing is a loading dose of 0.5 to 1.0 mcg/kg, usually followed by a continuous infusion of 0.2 to 0.7 mcg/kg&#x000a0;per hour&#x000a0;titrated to desired sedation goals. As mentioned, higher infusion doses can help achieve the desired effect.</p>
        <p>When used as an adjunct for peripheral nerve block, the dose of dexmedetomidine is usually 1 mcg/kg to achieve the desired prolongation.<xref ref-type="bibr" rid="article-20424.r15">[15]</xref></p>
      </sec>
      <sec id="article-20424.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>The most common adverse effects of dexmedetomidine are hypotension, bradycardia, and hypertension. Hypertension can result from the stimulation of alpha subtypes of receptors in vascular smooth muscles. Hypertension usually does not require treatment and can be avoided by the slow administration or omission of the loading dose. Hypotension and bradycardia are the results of the stimulation of presynaptic alpha receptors, which leads to a decreased release of norepinephrine; this is in addition to the decrease in the central sympathetic outflow. These are concerns regardless of the route of administration.<xref ref-type="bibr" rid="article-20424.r16">[16]</xref></p>
      </sec>
      <sec id="article-20424.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>There are no absolute contraindications to the use of dexmedetomidine. However, it should be used cautiously in patients with bradycardia and hypotension as the medication may exacerbate these findings.&#x000a0;Additionally, it should be used cautiously in patients with known heart failure as there is level B evidence showing dexmedetomidine can potentially exacerbate myocardial dysfunction.</p>
      </sec>
      <sec id="article-20424.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>There are no specific drug monitoring requirements. The level of sedation, heart rate/rhythm, blood pressure, and pulse oximetry requires close monitoring.</p>
      </sec>
      <sec id="article-20424.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>At present, there is no chemical reversal or antidote for dexmedetomidine. Supportive care and close monitoring are the staples of treatment for overdose.</p>
      </sec>
      <sec id="article-20424.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Dexmedetomidine is a useful non-opioid drug used to manage pain and sedation in&#x000a0;the ICU and operating room. The drug is effective, but its use does require monitoring of vital signs. Both the pharmacist and clinician should ensure the administration of the right dose to prevent adverse effects. ICU nurses should know that the drug requires caution in patients with heart failure. All these disciplines working collaboratively as an interprofessional healthcare team will optimize outcomes when using dexmedetomidine. [Level 5] The primary downside to dexmedetomidine is its cost.</p>
      </sec>
      <sec id="article-20424.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20424&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20424">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20424/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20424">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20424.s11">
        <title>References</title>
        <ref id="article-20424.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McLaughlin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marik</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Dexmedetomidine and delirium in the ICU.</article-title>
            <source>Ann Transl Med</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>224</fpage>
            <pub-id pub-id-type="pmid">27385042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Djaiani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Silverton</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fedorko</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Styra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Katznelson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial.</article-title>
            <source>Anesthesiology</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>124</volume>
            <issue>2</issue>
            <fpage>362</fpage>
            <page-range>362-8</page-range>
            <pub-id pub-id-type="pmid">26575144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reade</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Eastwood</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Bellomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bersten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Delaney</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Haren</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Harley</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McGuiness</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Donoghue</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Simpson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Young</surname>
                <given-names>P</given-names>
              </name>
              <collab>DahLIA Investigators</collab>
              <collab>Australian and New Zealand Intensive Care Society Clinical Trials Group</collab>
            </person-group>
            <article-title>Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated Delirium: A Randomized Clinical Trial.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Apr</month>
            <day>12</day>
            <volume>315</volume>
            <issue>14</issue>
            <fpage>1460</fpage>
            <page-range>1460-8</page-range>
            <pub-id pub-id-type="pmid">26975647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>ZT</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DX</given-names>
              </name>
              <name>
                <surname>Xue-Ying Li</surname>
              </name>
              <name>
                <surname>Maze</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Impact of Dexmedetomidine on Long-term Outcomes After Noncardiac Surgery in Elderly: 3-Year Follow-up of a Randomized Controlled Trial.</article-title>
            <source>Ann Surg</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>270</volume>
            <issue>2</issue>
            <fpage>356</fpage>
            <page-range>356-363</page-range>
            <pub-id pub-id-type="pmid">29742525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexopoulou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kondili</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Diamantaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Psarologakis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kokkini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bolaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Georgopoulos</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Effects of dexmedetomidine on sleep quality in critically ill patients: a pilot study.</article-title>
            <source>Anesthesiology</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>121</volume>
            <issue>4</issue>
            <fpage>801</fpage>
            <page-range>801-7</page-range>
            <pub-id pub-id-type="pmid">24988068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goucher Miranda</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Krystal</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Fierro</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Nocturnal Dexmedetomidine in Nonintubated, Critically Ill Patients: Sleep or Sedation?</article-title>
            <source>Anesthesiology</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>397</fpage>
            <page-range>397-398</page-range>
            <pub-id pub-id-type="pmid">28719531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blaudszun</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lysakowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tram&#x000e8;r</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Effect of perioperative systemic &#x003b1;2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials.</article-title>
            <source>Anesthesiology</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>116</volume>
            <issue>6</issue>
            <fpage>1312</fpage>
            <page-range>1312-22</page-range>
            <pub-id pub-id-type="pmid">22546966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Maslany</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Gorman</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McKay</surname>
                <given-names>WP</given-names>
              </name>
            </person-group>
            <article-title>Dexmedetomidine during total knee arthroplasty performed under spinal anesthesia decreases opioid use: a randomized-controlled trial.</article-title>
            <source>Can J Anaesth</source>
            <year>2016</year>
            <month>May</month>
            <volume>63</volume>
            <issue>5</issue>
            <fpage>569</fpage>
            <page-range>569-76</page-range>
            <pub-id pub-id-type="pmid">26830642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naik</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Nemergut</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Kazemi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fern&#x000e1;ndez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cederholm</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>McMurry</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Durieux</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>The Effect of Dexmedetomidine on Postoperative Opioid Consumption and Pain After Major Spine Surgery.</article-title>
            <source>Anesth Analg</source>
            <year>2016</year>
            <month>May</month>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>1646</fpage>
            <page-range>1646-53</page-range>
            <pub-id pub-id-type="pmid">27003917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>BN</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of intraoperative dexmedetomidine infusion on emergence agitation and quality of recovery after nasal surgery.</article-title>
            <source>Br J Anaesth</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>111</volume>
            <issue>2</issue>
            <fpage>222</fpage>
            <page-range>222-8</page-range>
            <pub-id pub-id-type="pmid">23524149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Davidson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Quraishi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schoenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sant</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Dexmedetomidine infusion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome undergoing tonsillectomy and adenoidectomy.</article-title>
            <source>Anesth Analg</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>111</volume>
            <issue>4</issue>
            <fpage>1004</fpage>
            <page-range>1004-10</page-range>
            <pub-id pub-id-type="pmid">20705788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deiner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Sessler</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Saager</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sieber</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Sano</surname>
                <given-names>M</given-names>
              </name>
              <collab>and the Dexlirium Writing Group</collab>
              <name>
                <surname>Jankowski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Bergese</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Candiotti</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Flaherty</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shander</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rock</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative Infusion of Dexmedetomidine for Prevention of Postoperative Delirium and Cognitive Dysfunction in Elderly Patients Undergoing Major Elective Noncardiac Surgery: A Randomized Clinical Trial.</article-title>
            <source>JAMA Surg</source>
            <year>2017</year>
            <month>Aug</month>
            <day>16</day>
            <volume>152</volume>
            <issue>8</issue>
            <fpage>e171505</fpage>
            <pub-id pub-id-type="pmid">28593326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kirksey</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Haskins</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>9</issue>
            <fpage>e0137312</fpage>
            <pub-id pub-id-type="pmid">26355598</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andersen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Grevstad</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Mathiesen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>J&#x000e6;ger</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Does Dexmedetomidine Have a Perineural Mechanism of Action When Used as an Adjuvant to Ropivacaine?: A Paired, Blinded, Randomized Trial in Healthy Volunteers.</article-title>
            <source>Anesthesiology</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>126</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-73</page-range>
            <pub-id pub-id-type="pmid">27792047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koyyalamudi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Creel</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Cornett</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fox</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Adjuvant Agents in Regional Anesthesia in the Ambulatory Setting.</article-title>
            <source>Curr Pain Headache Rep</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <pub-id pub-id-type="pmid">28210917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20424.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <article-title>Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2016</year>
            <month>Sep</month>
            <day>20</day>
            <volume>134</volume>
            <issue>12</issue>
            <fpage>e261</fpage>
            <pub-id pub-id-type="pmid">27647303</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
